Search

The Open Health Systems Colloquium and the International Bacteriophage Research Consortium will be hosting a lecture and panel discussion on "Charting a Path Toward Bacteriophage Therapy" on Nov. 19 from 6-8:30 PM at the India International

My name is Dr. Adamu Kaikabo Ahmad, currently working at National Veterinary Research Institute Vom, Nigeria. I hold a degree in Veterinary Medicine, and Master degree in Veterinary Science. I obtained my PhD in Bacteriology and Food Safety

My name is Dr. Adamu Kaikabo Ahmad, currently working at National Veterinary Research Institute Vom, Nigeria. I hold a degree in Veterinary Medicine, and Master degree in Veterinary Science. I obtained my PhD in Bacteriology and Food Safety

Have you heard about how phages have their own parasites? Here's a great tweet thread by Kim Seed of UC Berkeley explaining two new papers from her lab! The papers focus on understanding V. cholerae phage interactions with PLEs, phage-induc

If you haven't read Elio Schaechter's blog, Small Things Considered, you should take a look. This week he wrote a lovely post on flagellotropic phages and how phages "lasso" their host by the flagella, then glide down to the base for infect

Here's a shameless plug: we wrote a textbook chapter for Bacteriophages: Biology, Technology, Therapy, and it came out this week! We focus on how countries new to phage therapy are making compassionate phage therapy work (hint: collaboratio

Krystyna Dąbrowska (Polish Academy of Sciences) and Stephen Abedon (Ohio State University) have published a review on what it means to do "pharmacologically aware" phage therapy, which takes into consideration the in vivo obstacles to phage

Armata Pharmaceuticals has addressed its shareholders with good news about how their company is progressing post-merger between C3J and AmpliPhi. The company also recently announced that it has received a Research and Development Tax Incent

If you can get to Hamilton, Ontario Nov 14-15, check out the 2019 Gairdner Symposium: Fuelling the Fight Against Antimicrobial Resistance. Speakers include Dame Sally Davies (UK special envoy on AMR), Kevin Outterson (Director of CarbX), au

If you haven't read Elio Schaechter's blog, Small Things Considered, you should take a look. This week he wrote a lovely post on flagellotropic phages and how phages "lasso" their host by the flagella, then glide down to the base for infect

Here's a shameless plug: we wrote a textbook chapter for Bacteriophages: Biology, Technology, Therapy, and it came out this week! We focus on how countries new to phage therapy are making compassionate phage therapy work (hint: collaboratio

Have you heard about how phages have their own parasites? Here's a great tweet thread by Kim Seed of UC Berkeley explaining two new papers from her lab! The papers focus on understanding V. cholerae phage interactions with PLEs, phage-induc

Armata Pharmaceuticals has addressed its shareholders with good news about how their company is progressing post-merger between C3J and AmpliPhi. The company also recently announced that it has received a Research and Development Tax Incent

Krystyna Dąbrowska (Polish Academy of Sciences) and Stephen Abedon (Ohio State University) have published a review on what it means to do "pharmacologically aware" phage therapy, which takes into consideration the in vivo obstacles to phage

If you can get to Hamilton, Ontario Nov 14-15, check out the 2019 Gairdner Symposium: Fuelling the Fight Against Antimicrobial Resistance. Speakers include Dame Sally Davies (UK special envoy on AMR), Kevin Outterson (Director of CarbX), au

Why do bacteria evolve CRISPR-based phage resistance in natural environments, while in the lab, they seem to more readily evolve receptor-based resistance? Ellinor Alseth (University of Exeter) and colleagues have published a new paper digg

Engineering phages is getting more popular; here's another breakthrough in phage synthetic biology! Matthew Dunne (ETH Zurich) and colleagues have developed several approaches for engineering phages targeting Gram-positive pathogens (using

Is lyophilization a good way to store phages? Prasanth Manohar and Nachimuthu Ramesh (Vellore Institute of Technology) tested lyophilization conditions for three phages (an Escherichia phage, a Klebsiella phage and an Enterobacter phage) us

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc